The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug‐related problems
Open accessAbstract
What is already known about this subject • Polypharmacy has been linked to heightened risk of occurrence of drug‐related problems (DRPs) and a detrimental health outcome. • Polypharmacy has been variously defined; in research studies a commonly applied definition has been the concomitant use of five or more drugs. • The value of using a definite number of drugs as a cut‐off to describe polypharmacy as a risk factor for the occurrence of DRPs has not been validated. What this study adds • Nearly half of the patients admitted to general hospitals used five or more drugs; during the hospital stay these patients were prescribed as many new drugs as those admitted with fewer drugs. • The presence of DRPs increased approximately linearly with the number of drugs used, for the range of one to >11 drugs. • To set a strict cut‐off to identify polypharmacy and declare that using more than this number of drugs represents a potential risk for occurrence of DRPs, is of limited value in clinical practice. Aim: To investigate whether polypharmacy defined as a definite number of drugs is a suitable indicator for describing the risk of occurrence of drug‐related problems (DRPs) in a hospital setting. Methods: Patients admitted to six internal medicine and two rheumatology departments in five hospitals were consecutively included and followed during the hospital stay, with particular attention to medication and DRPs. Comparisons were made between patients admitted with five or more drugs and with less than five drugs. Clinical pharmacists assessed DRPs by reviewing medical records and by participating in multidisciplinary team discussions. Results: Of a total of 827 patients, 391 (47%) used five or more drugs on admission. Patients admitted with five or more and less than five drugs were prescribed the same number of drugs after admission: 4.1 vs. 3.9 drugs [P = 0.4, 95% confidence interval (CI) − 0.57, 0.23], respectively. The proportion of drugs used on admission which was associated with DRPs was similar in the patient group admitted with five or more drugs and in those admitted with less than five drugs. The number of DRPs per patient increased approximately linearly with the increase in number of drugs used; one unit increase in number of drugs yielded a 8.6% increase in the number of DRPs (95% CI 1.07, 1.10). Conclusion: The number of DRPs per patient was linearly related to the number of drugs used on admission. To set a strict cut‐off to identify polypharmacy and declare that using more than this number of drugs represents a potential risk for occurrence of DRPs, is of limited value when assessing DRPs in a clinical setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Treatment of Unrelated Disorders in Patients with Chronic Medical Diseases
Redelmeier, D. A., Tan, S. H., & Booth, G. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382106 · Cited by 635
Drug-Related Problems: Their Structure and Function
Strand, L. M., Morley, P. C., Cipolle, R. J., Ramsey, R., & Lamsam, G. D. (1990) · DICP · doi:10.1177/106002809002401114 · Cited by 569
Polypharmacy in the elderly: A literature review
Fulton, M. M., & Riley Allen, E. (2005) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1041-2972.2005.0020.x · Cited by 540
Use of medications and polypharmacy are increasing among the elderly
Linjakumpu, T., Hartikainen, S., Klaukka, T., Veijola, J., Kivelä, S.-L., & Isoaho, R. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00411-0 · Cited by 509
Association between falls in elderly women and chronic diseases and drug use: cross sectional study
Lawlor, D. A., Patel, & Ebrahim, S. (2003) · BMJ · doi:10.1136/bmj.327.7417.712 · Cited by 444
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Health Outcomes and Polypharmacy in Elderly Individuals
Frazier, S. C. (2005) · Journal of Gerontological Nursing · doi:10.3928/0098-9134-20050901-04 · Cited by 268
Polypharmacy and Hospitalization Among Older Home Care Patients
Flaherty, J. H., Perry, H. M., Lynchard, G. S., & Morley, J. E. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.10.m554 · Cited by 236
Blix, H. S., Viktil, K. K., Reikvam, �., Moger, T. A., Hjemaas, B. J., Pretsch, P., Vraalsen, T. F., & Walseth, E. K. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0830-4 · Cited by 212
Self-citationAdverse Outcomes Associated with Inappropriate Drug Use in Nursing Homes
Perri, M., Menon, A. M., Deshpande, A. D., Shinde, S. B., Jiang, R., Cooper, J. W., Cook, C. L., Griffin, S. C., & Lorys, R. A. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e230 · Cited by 208
Cited by
What is polypharmacy? A systematic review of definitions
Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0621-2 · Cited by 3,293
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
Kantor, E. D., Rehm, C. D., Haas, J. S., Chan, A. T., & Giovannucci, E. L. (2015) · JAMA · doi:10.1001/jama.2015.13766 · Cited by 1,219
Predicting risk of adverse drug reactions in older adults
Lavan, A. H., & Gallagher, P. (2016) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098615615472 · Cited by 455
An overview of prevalence, determinants and health outcomes of polypharmacy
Khezrian, M., McNeil, C. J., Murray, A. D., & Myint, P. K. (2020) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098620933741 · Cited by 443
Polypharmacy Status as an Indicator of Mortality in an Elderly Population
Jyrkkä, J., Enlund, H., Korhonen, M. J., Sulkava, R., & Hartikainen, S. (2009) · Drugs & Aging · doi:10.2165/11319530-000000000-00000 · Cited by 346
On behalf of SIMI Investigators, Nobili, A., Licata, G., Salerno, F., Pasina, L., Tettamanti, M., Franchi, C., De Vittorio, L., Marengoni, A., Corrao, S., et al. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0977-0 · Cited by 312
Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many
Cadogan, C. A., Ryan, C., & Hughes, C. M. (2016) · Drug Safety · doi:10.1007/s40264-015-0378-5 · Cited by 298
Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008
Hovstadius, B., Hovstadius, K., Åstrand, B., & Petersson, G. (2010) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-10-16 · Cited by 290
Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions
Magro, L., Moretti, U., & Leone, R. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.631910 · Cited by 287
Polypharmacy in elderly patients with cancer: clinical implications and management
Lees, J., & Chan, A. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70040-7 · Cited by 271
Medication Non-Adherence Among Elderly Patients Newly Discharged and Receiving Polypharmacy
Pasina, L., Brucato, A. L., Falcone, C., Cucchi, E., Bresciani, A., Sottocorno, M., Taddei, G. C., Casati, M., Franchi, C., Djade, C. D., et al. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0163-7 · Cited by 263
Psychotropic Medication Patterns Among Youth in Foster Care
Zito, J. M., Safer, D. J., Sai, D., Gardner, J. F., Thomas, D., Coombes, P., Dubowski, M., & Mendez-Lewis, M. (2008) · Pediatrics · doi:10.1542/peds.2007-0212 · Cited by 254
The clinical implications of ageing for rational drug therapy
Shi, S., Mörike, K., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0422-1 · Cited by 244
Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem
Parsons, C. (2017) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098616670798 · Cited by 113
“…with age-related changes in drug pharmacokinetics and pharmacodynamics, multimorbidity and polypharmacy are widely regarded as key predisposing factors for adverse drug reactions (ADRs) [Mangoni & Jackson, 2004; Viktil et al. 2007; Cherubini et al. 2011; Petrovic et al. 2012; Onder et al. 2013].”
Background
Metadata
- Authors
- Viktil, K. K., Blix, H. S., Moger, T. A., & Reikvam, A.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2006-08-30
- Volume
- 63
- Issue
- 2
- Pages
- 187-195
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2024620182
- Cited by
- 537
- References
- 24
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.